1301-25-R-RFIN-00005

The Mississippi State Department of Health is pursuing a sole source procurement for Yellow Fever Vaccine through solicitation #1301-25-R-RFIN-00005. The procurement specifically targets Sanofi Pasteur, Inc. as the sole potential vendor for this vaccine acquisition. Potential vendors or interested parties have until September 18, 2024 at 10:00 a.m. (CST) to submit written objections challenging the sole source determination. If no valid objections are received, the Department will proceed with the procurement directly through Sanofi Pasteur, Inc. In the event that objections demonstrate alternative vaccine sources exist, the Department will withdraw the sole source request and convert the procurement to a competitive bidding process. The solicitation is structured to allow comprehensive review by the Public Procurement Review Board, which will ultimately validate whether a single source truly exists for the required Yellow Fever Vaccine.

The procurement appears to be unrestricted regarding vendor set-asides or specific enterprise designations. No explicit budget range or award value was specified in the available documentation. The sole source nature of the procurement suggests this is a targeted acquisition with specific requirements that potentially cannot be met by multiple vendors. While Sanofi Pasteur, Inc. is the anticipated vendor, the document leaves open the possibility of alternative sources if compelling evidence is presented. The procurement process allows for transparent challenge and review, ensuring that the sole source determination is thoroughly vetted before final award. No information was provided about incumbent vendors, existing infrastructure, or technology integration requirements specific to this vaccine procurement.